Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

China National Biotechnology to IPO on the Hong Kong Exchange

publication date: Nov 4, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
China National Biotechnology Group (CNBG) plans a Hong Kong IPO, according to Zhiping Song, Chairman of its parent, China National Pharmaceutical Group Corporation (SinoPharm Group). CNBG, which will change its name to China Biotech, is comprised of six institutes of biological products. So far, no predictions of the size of the offering have been published. More details....

Share this with colleagues:  

This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners